Results 121 to 130 of about 12,862 (201)

Repurposing antiviral drugs targeting RNA viruses: A focus on the fusion protein of human metapneumovirus. [PDF]

North Clin Istanb
Aras M, Yayintas OT.
europepmc   +1 more source

Clinical, Economic, and Humanistic Impact of Sofosbuvir-Based Regimens in Hepatitis C

, 2015
Objective: A retrospective data analysis was conducted on real-world data for treatment-naïve and treatment-experienced patients with hepatitis C. Real-world effectiveness values were used to populate an economic model for genotype 1 patients with ...
Parekh, Mousam
core  

Comparative effectiveness of antiviral therapies in chronic hepatitis B and C management. [PDF]

Bioinformation
Tiwari A, Tagore PK, Kumhar SD, Bardiya A.   +3 more
europepmc   +1 more source

Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection. [PDF]

Pharmaceuticals (Basel)
Dybowska D, Pawłowska M, Kozielewicz D.
europepmc   +1 more source

Histopathological features and eight-week split-tablet sofosbuvir/velpatasvir treatment in young children with acute hepatitis C: a case-series study. [PDF]

BMC Infect Dis
Pan YJ, Chen RY, Ai YQ, Zeng QL.
europepmc   +1 more source

Mechanism of SARS-CoV-2 resistance to nucleotide analog-based antivirals. [PDF]

Nat Commun
Liu C, Li Y, Cao X, Gleason RJ, Liu B, Yang Y.   +5 more
europepmc   +1 more source

A Database-Derived Global Overview of HCV Resistance-Associated Substitutions: Characterizing Genotypic, Regional, and Temporal Heterogeneity. [PDF]

Int J Mol Sci
Nunes GTM, Sant'Anna TBF, de Araujo NM.
europepmc   +1 more source

Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan. [PDF]

J Viral Hepat
Shah S, Mafirakureva N, Trickey A, Hasnain A, Khan U, Khowaja S, Ashraf H, Baig-Ansari N, Hickman M, Vickerman P, Walker JG, Lim AG.   +11 more
europepmc   +1 more source

Identification of NS5B resistance-associated mutations in hepatitis C virus circulating in treatment-naïve Cameroonian patients. [PDF]

IJID Reg
Mounchili-Njifon A, Modiyinji AF, Mbouyap PR, Monamele CG, Moumbeket-Yifomnjou MH, Mfombouot PHN, Machuetum GL, Toueyem PI, Lissock SF, Tagnouokam-Ngoupo PA, Assam JPA, Njouom R.   +11 more
europepmc   +1 more source

Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Teymourzadeh E, Salesi M, Keshavarz K, Abyazi MA, Heiat M, Alavian SM.   +7 more
europepmc   +1 more source